MIP PHARMA DANMARK ApS: Financial statements 2022
CVR: 32886280
Source: annual report 2022, Danish Business Authority
01/07/2021 – 30/06/2022
MIP PHARMA DANMARK ApS (CVR 32886280) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -48,214 and a net result of DKK -79,066 compared with DKK -52,682 the year before. Equity in the 2022 report amounted to DKK -386,851.
- Gross Profit
- DKK -48,214
- Profit/Loss
- DKK -79,066
- Equity
- DKK -386,851
- Total Assets
- DKK 24,600
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -48 t. | -79 t. | -387 t. | - |
| 2021 | - | -39 t. | -53 t. | -308 t. | - |
| 2020 | - | -24 t. | -38 t. | -255 t. | 0 |
| 2019 | - | -23 t. | -33 t. | -217 t. | 0 |
| 2018 | - | -27 t. | -35 t. | -184 t. | 0 |
Official annual report
Keep an eye on MIP PHARMA DANMARK ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout MIP PHARMA DANMARK ApS
MIP PHARMA DANMARK ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2010. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Jochen Steinhage. The company is owned by MIP Pharma GmbH. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -129,052 and a net result of DKK -155,646 compared with DKK -109,135 the year before. Equity in the 2025 report amounted to DKK -716,683.